Qube Research & Technologies LTD Cor Medix Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Cor Medix Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 215,220 shares of CRMD stock, worth $2.44 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
215,220
Previous 123,500
74.27%
Holding current value
$2.44 Million
Previous $760,000
248.82%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CRMD
# of Institutions
188Shares Held
33.2MCall Options Held
867KPut Options Held
561K-
Vanguard Group Inc Valley Forge, PA4.33MShares$49 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.3 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.58MShares$29.2 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.71MShares$19.4 Million0.0% of portfolio
-
State Street Corp Boston, MA1.6MShares$18.1 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $467M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...